Abstract. Most of the identified constituents of the filamentous inclusions characteristic of the neurodegenerative diseases of aging are derived from the cytoskeleton. This study was undertaken to define immunocytochemically the cytoskeletal constituents of the filamentous cytopathologic marker of idiopathic Parkinson disease, the Lewy body (LB). An array of antibodies specific to neurofilaments, tubulin, microtubule associated proteins (tau, MAP I and MAP2) and Alzheimer neurofibrillary tangles (NfT) were used to immunostain sections containing LB. All the antibodies to tubulin, MAP I and MAP2 and the majority of the antibodies to neurofilaments and Nf'T recognized LB. The two monoclonal antibodies to Nf'T that recognize LB also react with ubiquitin, which has been identified in Nf'T, The prominent Nf'T component, tau, is apparently not incorporated into LB. These findings suggest that the presence oftau might not be a prerequisite to the formation ofabnormal filaments. Therefore, although LB contain elements ofneurofilaments, microtubules and ubiquitin, as do other abnormal neuronal filaments, they are distinct in composition. These distinctive and shared features may provide useful insights regarding the mechanisms underlying the formation of filaments in LB as well as those of other neuronal inclusions.
INTRODUCTION
Lewy bodies (LB) are the characteristic intracytoplasmic inclusion of neurons in idiopathic Parkinson's disease, a degenerative condition of the central nervous systern-(CNS). They are composed of a dense core, often containing granules, circular profiles and vesicles, surrounded by radiating filaments varying in diameter from 7.5 to 20 nm (1, 2). Primarily located in pigmented neurons of the locus ceruleus and substantia nigra (3), they have been reported in other sites in the CNS and peripheral nervous system, including the non-pigmented brainstem nuclei, the nucleus basalis of Meynert, hypothalamus, and less commonly in the fifth and sixth layers of the cerebral cortex and the intermediolateral cell columns of the spinal cord (4).
The components and cellular precursors of LB have been difficult to define. This is because (as for other neuronal inclusions in degenerative disease of the CNS) their direct biochemical examination has been impeded by the lack ofa pure fraction. Consequently, there has been a reliance on structural, histochemical and immunocytochemical approaches to identify the elements of LB. Consistent with the non- Supported by an American Cancer Society Grant (Cuyahoga County Unit) and NIH Grants AG00795, AG05892, NSI8105 and AGINS04220. 654 by guest on October 8, 2016
